A detailed history of Cx Institutional transactions in Organon & Co. stock. As of the latest transaction made, Cx Institutional holds 460 shares of OGN stock, worth $3,022. This represents 0.0% of its overall portfolio holdings.

Number of Shares
460
Previous 390 17.95%
Holding current value
$3,022
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

BUY
$8.4 - $10.85 $588 - $759
70 Added 17.95%
460 $5,000
Q1 2025

Apr 15, 2025

BUY
$14.29 - $16.41 $5,573 - $6,399
390 New
390 $6,000
Q2 2022

Aug 02, 2022

BUY
$31.66 - $38.9 $45,273 - $55,627
1,430 New
1,430 $48,000
Q4 2021

Jan 18, 2022

SELL
$28.67 - $37.13 $33,285 - $43,107
-1,161 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$28.63 - $35.64 $31,807 - $39,596
-1,111 Reduced 48.9%
1,161 $38,000
Q2 2021

Aug 04, 2021

BUY
$28.45 - $38.0 $64,638 - $86,336
2,272 New
2,272 $69,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.67B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Cx Institutional Portfolio

Follow Cx Institutional and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

News

Stay updated on Cx Institutional with notifications on news.